Equities

Shilpa Medicare Ltd

SHILPAMED:NSI

Shilpa Medicare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)866.65
  • Today's Change16.60 / 1.95%
  • Shares traded224.04k
  • 1 Year change+145.16%
  • Beta0.9436
Data delayed at least 15 minutes, as of Sep 20 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments302213338
Total Receivables, Net4,6733,9474,637
Total Inventory3,6123,4393,828
Prepaid expenses1587865
Other current assets, total23183.73
Total current assets8,7687,6968,872
Property, plant & equipment, net15,96215,37514,036
Goodwill, net462455457
Intangibles, net4,6124,4063,987
Long term investments466598507
Note receivable - long term423503882
Other long term assets730.520.00
Total assets30,93229,03928,755
LIABILITIES
Accounts payable1,7481,4281,460
Accrued expenses347353365
Notes payable/short-term debt3,6073,4422,029
Current portion long-term debt/capital leases1521,6311,256
Other current liabilities, total1,0789911,005
Total current liabilities6,9337,8446,115
Total long term debt5,6142,9063,547
Total debt9,3747,9796,833
Deferred income tax0141547
Minority interest(87)(89)(110)
Other liabilities, total385405433
Total liabilities12,84511,20610,533
SHAREHOLDERS EQUITY
Common stock878787
Additional paid-in capital7,2507,2507,250
Retained earnings (accumulated deficit)10,85610,53010,950
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(106)(34)(65)
Total equity18,08717,83318,222
Total liabilities & shareholders' equity30,93229,03928,755
Total common shares outstanding878787
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.